RISK OF KIDNEY DISEASE PROGRESSION AND EFFICACY OF SGLT2 INHIBITION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

被引:0
|
作者
Moura, Filipe [1 ]
Berg, David [1 ]
Bellavia, Andrea [1 ]
Mosenzon, Ofri [1 ]
Dwyer, Jamie [1 ]
Scirica, Benjamin M. [1 ]
Wiviott, Stephen [1 ]
Bhatt, Deepak L. [1 ]
Raz, Itamar [1 ]
Feinberg, Mark William [1 ]
Morrow, David A. [1 ]
Sabatine, Marc Steven [1 ]
机构
[1] Brigham & Womens Hosp, Boston, MA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1493-176
引用
收藏
页码:1808 / 1808
页数:1
相关论文
共 50 条
  • [31] The effect of SGLT2 inhibitors on drugnaive obese type 2 diabetes mellitus patients
    Chikazawa, Shinji
    Matsuhashi, Yuki
    Tando, Yusuke
    Daimon, Makoto
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S103 - S103
  • [32] SGLT2 inhibition in diabetes mellitus: rationale and clinical prospects
    Ferrannini, Ele
    Solini, Anna
    NATURE REVIEWS ENDOCRINOLOGY, 2012, 8 (08) : 495 - 502
  • [34] Sodium-Glucose Cotransporter 2 (SGLT2) Inhibition in Kidney Transplant Recipients with Diabetes Mellitus
    Mahling, Moritz
    Schork, Anja
    Nadalin, Silvio
    Fritsche, Andreas
    Heyne, Nils
    Guthoff, Martina
    KIDNEY & BLOOD PRESSURE RESEARCH, 2019, 44 (05): : 984 - 992
  • [35] Safety of SGLT2 Inhibitors in Patients with Diabetes Mellitus
    Singh, Mahakpreet
    Sharma, Ruchika
    Kumar, Anoop
    CURRENT DRUG SAFETY, 2019, 14 (02) : 87 - 93
  • [37] Role of SGLT2 inhibitors in the treatment of type 2 diabetes mellitus
    Anna Solini
    Acta Diabetologica, 2016, 53 : 863 - 870
  • [38] Canagliflozin: A Novel SGLT2 Inhibitor for Type 2 Diabetes Mellitus
    Kaushal, Shaveta
    Singh, Harmanjit
    Thangaraju, Pugazhenthan
    Singh, Jasbir
    NORTH AMERICAN JOURNAL OF MEDICAL SCIENCES, 2014, 6 (03) : 107 - 113
  • [39] SGLT2 Inhibition in Kidney Transplant Recipients with Diabetes.
    Guthoff, M.
    Mahling, M.
    Nadalin, S.
    Heyne, N.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 554 - 554
  • [40] Systematic review and meta-analysis of the efficacy and safety of SGLT2 inhibitors in patients with type 2 diabetes mellitus
    Tsapas, A.
    Vassilakou, D.
    Athanasiadou, E.
    Karagiannis, T.
    Matthews, D. R.
    DIABETOLOGIA, 2012, 55 : S107 - S107